The value of evidence lies not only in what it shows, but in the decisions it helps us make.
From Evidence to Better Decisions
Dear Colleagues,
The hardest question in medicine is often not whether a study produced a significant result. It is whether that result should change the decision we make for the patient in front of us.
In this November issue of Medeasy Review, we examine that challenge across several areas of clinical practice.
Our main feature explores the evolving approach to type 2 diabetes, asking whether earlier organ-protective treatment can be meaningfully integrated into Philippine healthcare. We also revisit fluid and vasopressor strategies in septic shock, evaluate emerging biologic therapies for COPD, and examine what local antimicrobial resistance data mean for prescribing decisions.
Beyond new treatments, we consider an equally important question: are we identifying the right patients, using the right evidence, and measuring outcomes that truly matter?
New evidence deserves attention. But better care requires interpretation, clinical judgment, and an understanding of the healthcare setting in which decisions are made.
Thank you for being part of the Medeasy physician community.
Warm regards,
Medeasy Review Editorial Team
“ The value of evidence lies not only in what it shows, but in the decisions it helps us make.
